HYBI:NSD-HYBI (USD)

ETF | Others |

Last Closing

USD 10.243

Change

-0.07 (-0.70)%

Market Cap

USD 0.14B

Volume

0.09M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

+3.36 (+6.36%)

USD 53.00B
QQQM Invesco NASDAQ 100 ETF

+2.93 (+1.36%)

USD 38.88B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.48 (+0.83%)

USD 20.37B
ACWI iShares MSCI ACWI ETF

+1.00 (+0.84%)

USD 19.97B
CGABL The Carlyle Group Inc. 4.625% ..

-0.04 (-0.20%)

USD 16.14B
NVDL GraniteShares 1.5x Long NVDA D..

+0.57 (+0.79%)

USD 5.35B
TSLL Direxion Shares ETF Trust - Di..

+4.57 (+14.35%)

USD 5.32B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.01 (+0.02%)

USD 4.54B
ETHA iShares Ethereum Trust ETF

+0.82 (+3.18%)

USD 3.54B
USCL iShares Climate Conscious & Tr..

+0.81 (+1.13%)

USD 2.64B

ETFs Containing HYBI

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.14B 71% C- 42% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike